Home › T-Cell Lymphoma › Nebraska
T-Cell Lymphoma clinical trials in Nebraska
3 studies for T-Cell Lymphoma are looking for participants at sites in Nebraska.
Cities in Nebraska
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
- Nebraska Medicine-Bellevue, Bellevue
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT04803201A Registry for People With T-cell Lymphoma
- University of Nebraska (Data collection only), Omaha
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141MB-105 in Patients With CD5 Positive T-cell Lymphoma
- University of Nebraska, Omaha
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 3, 2025 · NCT06534060From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.